… A prior liver disease might exaggerate the damage from ongoing COVID-19 infection.
Non-alcoholic fatty liver disease might represent per se a condition of intrinsic frailty (due to …

… . describe the implication of non-alcoholic fatty liver disease (NAFLD) on clinical outcomes
in patients with SARS-CoV-2 infection. They reported that the prevalence NAFLD was 37.6%, …

… against coronavirus disease 2019 (COVID-19) … COVID-19 vaccine appears to be safe with
good immunogenicity in the large population of patients with non-alcoholic fatty liver disease…

… clinical characteristics of coronavirus disease 2019 in China. … Non-alcoholic fatty liver
diseases in patients with COVID-19: … pitalized patients with coronavirus disease 2019 (COVID-19) …

… Coronaviruses are enveloped viruses that display the largest genome of … coronavirus 2
(SARS-CoV-2) is responsible for the novel coronavirus disease that first occurred in 2019 (COVID…

… of coronavirus disease 2019 (COVID-19) and non-alcoholic … in both diseases (in pre-existing
non-alcoholic fatty liver disease). F. … COVID-19 may trigger acute-on-chronic liver failure in …

… non-alcoholic fatty liver disease (NAFLD) on the susceptibility and consequences of
coronavirus disease 2019 (COVID… We retrospectively collected data from 218 adult COVID-19 …

… clinical consequences of coronavirus disease 2019 (COVID-19) … of NAFLD and the risk of
SARS-CoV-2 infectivity and COVID-… liver cirrhosis,4 liver-transplant recipient,5 and chronic liver …

… Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of chronic …
, a drug recognized to cause significant liver damage or induce liver failure [7]. SARS-CoV-2 …

… city of Wuhan, Hubei province, China, in December 2019. Soon after, it became a global
burden as … It has been documented that people with liver diseases, especially liver cirrhosis and …